Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases

The ongoing COVID-19 pandemic required a firm and prompt effort in the development of an effective vaccine. Reports of adverse reactions are increasing. Lichen planus, as well as its oral variant, is a condition that has previously been reported to be associated with vaccines. This is one of the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Raccampo, Luca, Sembronio, Salvatore, Tel, Alessandro, Cacitti, Veronica, Robiony, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995197/
https://www.ncbi.nlm.nih.gov/pubmed/35851250
http://dx.doi.org/10.1016/j.oooo.2022.04.003
Descripción
Sumario:The ongoing COVID-19 pandemic required a firm and prompt effort in the development of an effective vaccine. Reports of adverse reactions are increasing. Lichen planus, as well as its oral variant, is a condition that has previously been reported to be associated with vaccines. This is one of the first reports of oral lichen planus (OLP) arising after any COVID-19 vaccine. Here the authors present 2 cases of OLP that occurred after BNT162b2 mRNA COVID-19 vaccination (Comirnaty, Pfizer, New York, NY, USA; BioNTech, Mainz, Germany).

Ejemplares similares